NEW YORK (GenomeWeb) – Alere today said that it intends to offer $425 million of senior subordinated notes through a private placement. 

The notes are due 2023, and proceeds from the offering will be used to redeem the firm's outstanding $400 million aggregate principal amount of 8.625 percent senior subordinated notes due 2018. The private placement is expected to begin immediately, Alere said. 

The firm said that the notes will not be registered under US securities law and as a result will not be offered or sold in the US.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

The Atlantic reports that genetic counselors are coping with an influx of patients seeking advice on their direct-to-consumer genetic test results.

A small study finds differences between three genomic prostate cancer tests, Medscape reports.

In Nature this week: shared genetic architecture for asthma and allergic diseases, and more.

A survey of Canadians finds them to be divided on genetically modified food, the Ottawa Citizen reports.